Argenx to host r&d webinar highlighting argx-119 on september 16, 2025

August 19, 2025 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled “r&d spotlight | pioneering musk biology with argx-119” on tuesday, september 16, 2025, at 2:00pm et.
ARGX Ratings Summary
ARGX Quant Ranking